Keyphrases
In Cancer
100%
Drug Resistance
100%
Cancer Cells
100%
Microenvironment
100%
Resistant Cells
50%
Drug-free
50%
Tumor
25%
Erlotinib
25%
Tumor Cells
25%
Process-based
25%
Mathematical Model
25%
Evolutionary Dynamics
25%
Tumor Microenvironment
25%
Computational Approach
25%
Chemotherapy Resistance
25%
Selective Pressure
25%
Drug Sensitivity
25%
Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor (EGFR-TKI)
25%
Recurrence Rate
25%
Heterogeneous Cell Population
25%
Human Lung Cancer Cell Line
25%
Non-small Cell Lung Cancer Cells
25%
Tumor Recurrence
25%
Cellular Compartments
25%
Evolutionary Process
25%
Environmental Niche
25%
Fitness Advantage
25%
Selective Effect
25%
Dynamic Feedback
25%
HCC827
25%
Nutrient Gradient
25%
Experimental Dataset
25%
Drug Gradient
25%
Tumor Composition
25%
Medicine and Dentistry
Cancer Cell
100%
Non Small Cell Lung Cancer
100%
Drug Resistance in Cancer
100%
Evolution
100%
Neoplasm
50%
Tumor Microenvironment
50%
Tumor Cell
50%
Specific Tumor
50%
Erlotinib
50%
Recurrent Disease
50%
Cell Population
50%
Lung Cancer Cell Line
50%
Cellular Compartment
50%
Epidermal Growth Factor Receptor Kinase Inhibitor
50%
Drug Resistance
50%
Immunology and Microbiology
Drug Resistance
100%
Evolution
100%
Cancer Cell
100%
Dynamics
50%
Tumor Cell
50%
Cell Population
50%
Lung Cancer Cell Line
50%
Epidermal Growth Factor
50%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Drug Resistance
100%
Evolution
66%
Dynamics
33%
Erlotinib
33%
Receptor Tyrosine Kinase Inhibitors
33%
Epidermal Growth Factor Receptor
33%
Engineering
Microenvironments
100%
Model System
33%
Endpoint
33%
Directionality
33%
Recurrence Time
33%
Sensitive Cell
33%
Phase Composition
33%
Mathematical Model
33%
Neuroscience
Drug Resistance
100%
Erlotinib
50%
Receptor Tyrosine Kinase Inhibitors
50%
Cell Line
50%
Epidermal Growth Factor Receptor
50%